{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:07:27Z","timestamp":1790251647177,"version":"4.1.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":115,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"DOI":"10.1186\/s13019-026-04270-y","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T15:04:28Z","timestamp":1780326268000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Alpha-gal xenoantigens in bioprosthetic valve recipients: clinical implications for bioprosthesis longevity"],"prefix":"10.1186","volume":"21","author":[{"given":"Jack","family":"Gosden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Ascione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph W.","family":"Turek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"issue":"7","key":"4270_CR1","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1080\/1744666X.2020.1782745","volume":"16","author":"SP Commins","year":"2020","unstructured":"Commins SP. Diagnosis & management of Alpha-Gal Syndrome: lessons from 2,500 patients. Expert Rev Clin Immunol. 2020;16(7):667\u201377. https:\/\/doi.org\/10.1080\/1744666X.2020.1782745.","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"4270_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00239-014-9652-x","volume":"80","author":"U Galili","year":"2015","unstructured":"Galili U. Significance of the evolutionary \u03b11,3-galactosyltransferase (GGTA1) gene inactivation in preventing extinction of apes and Old World monkeys. J Mol Evol. 2015;80(1):1\u20139. https:\/\/doi.org\/10.1007\/s00239-014-9652-x.","journal-title":"J Mol Evol"},{"issue":"2\u20133","key":"4270_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/BF00201098","volume":"15","author":"U Galili","year":"1993","unstructured":"Galili U. Evolution and pathophysiology of the human natural anti-alpha-galactosyl IgG (anti-Gal) antibody. Springer Semin Immunopathol. 1993;15(2\u20133):155\u201371. https:\/\/doi.org\/10.1007\/BF00201098.","journal-title":"Springer Semin Immunopathol"},{"issue":"5","key":"4270_CR4","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.jaci.2011.02.019","volume":"127","author":"SP Commins","year":"2011","unstructured":"Commins SP, James HR, Kelly LA, Pochan SL, Workman LJ, Perzanowski MS, et al. The relevance of tick bites to the production of IgE antibodies to the mammalian oligosaccharide galactose-\u03b1-1,3-galactose. J Allergy Clin Immunol. 2011;127(5):1286-93.e6. https:\/\/doi.org\/10.1016\/j.jaci.2011.02.019.","journal-title":"J Allergy Clin Immunol"},{"key":"4270_CR5","unstructured":"Yale Medicine. Alpha-gal Syndrome (AGS) [Internet]. New Haven (CT): Yale Medicine; [cited 2025 Aug 14]. Available from: https:\/\/www.yalemedicine.org\/conditions\/alpha-gal-syndrome-ags"},{"key":"4270_CR6","unstructured":"Mayo Clinic Staff. Alpha\u2013gal syndrome \u2013 Symptoms & causes [Internet]. Rochester (MN): Mayo Clinic; 2025 Aug 8 [cited 2025 Aug 14]. Available from: https:\/\/www.testcatalog.org\/show\/ALGAL"},{"key":"4270_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01056","volume":"10","author":"G Crispell","year":"2019","unstructured":"Crispell G, Commins SP, Archer-Hartman SA, Choudhary S, Dharmarajan G, Azadi P, et al. Discovery of Alpha-Gal-containing antigens in North American tick species believed to induce red meat allergy. Front Immunol. 2019;10:1056. https:\/\/doi.org\/10.3389\/fimmu.2019.01056.","journal-title":"Front Immunol"},{"issue":"6","key":"4270_CR8","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1111\/all.16003","volume":"79","author":"JM Wilson","year":"2024","unstructured":"Wilson JM, Erickson L, Levin M, Ailsworth SM, Commins SP, Platts-Mills TAE. Tick bites, IgE to galactose-alpha-1,3-galactose and urticarial or anaphylactic reactions to mammalian meat: the Alpha-Gal Syndrome. Allergy. 2024;79(6):1440\u201354. https:\/\/doi.org\/10.1111\/all.16003.","journal-title":"Allergy"},{"key":"4270_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/falgy.2025.1535103","volume":"6","author":"SBH Propst","year":"2025","unstructured":"Propst SBH, Thompson DK. Alpha-Gal Syndrome and the gastrointestinal reaction: a narrative review. Front Allergy. 2025;6:1535103. https:\/\/doi.org\/10.3389\/falgy.2025.1535103.","journal-title":"Front Allergy"},{"issue":"11","key":"4270_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-245488","volume":"14","author":"E Altshuler","year":"2021","unstructured":"Altshuler E, Krikpatrick J, Aryan M, Miralles F. Mammalian meat allergy emerges after tick bite: the Alpha-Gal Syndrome. BMJ Case Rep. 2021;14(11):e245488. https:\/\/doi.org\/10.1136\/bcr-2021-245488.","journal-title":"BMJ Case Rep"},{"key":"4270_CR11","unstructured":"Centers for Disease Control and Prevention. About Alphagal Syndrome [Internet]. Atlanta (GA): Centers for Disease Control and Prevention; 2025 Jun 26 [cited 2025 Aug 14]. Available from: https:\/\/www.cdc.gov\/alphagalsyndrome\/about\/index.html"},{"issue":"4","key":"4270_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pclm.0000528","volume":"4","author":"BD Hollingsworth","year":"2025","unstructured":"Hollingsworth BD, Wiener M, Giandomenico DA, Commins SP, Boyce RM. Environmental risk and Alpha\u2011gal Syndrome (AGS) in the Mid\u2011Atlantic United States. PLoS Clim. 2025;4(4):e0000528. https:\/\/doi.org\/10.1371\/journal.pclm.0000528.","journal-title":"PLoS Clim"},{"issue":"6","key":"4270_CR13","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1016\/j.athoracsur.2020.07.050","volume":"111","author":"RB Hawkins","year":"2021","unstructured":"Hawkins RB, Wilson JM, Mehaffey JH, Platts-Mills TAE, Ailawadi G. Safety of intravenous heparin for cardiac surgery in patients with Alpha-Gal Syndrome. Ann Thorac Surg. 2021;111(6):1991\u20137. https:\/\/doi.org\/10.1016\/j.athoracsur.2020.07.050.","journal-title":"Ann Thorac Surg"},{"key":"4270_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g401","volume":"348","author":"KC Tatham","year":"2014","unstructured":"Tatham KC, Patel KP. Suitability of common drugs for patients who avoid animal products. BMJ. 2014;348:g401. https:\/\/doi.org\/10.1136\/bmj.g401.","journal-title":"BMJ"},{"key":"4270_CR15","doi-asserted-by":"publisher","DOI":"10.1177\/2041731417726327","volume":"8","author":"MC VeDepo","year":"2017","unstructured":"VeDepo MC, Detamore MS, Hopkins RA, Converse GL. Recellularization of decellularized heart valves: progress toward the tissue-engineered heart valve. J Tissue Eng. 2017;8:2041731417726327. https:\/\/doi.org\/10.1177\/2041731417726327.","journal-title":"J Tissue Eng"},{"issue":"6","key":"4270_CR16","doi-asserted-by":"publisher","first-page":"e411","DOI":"10.1016\/j.jtcvs.2021.03.100","volume":"164","author":"KV Kuravi","year":"2022","unstructured":"Kuravi KV, Sorrells LT, Nellis JR, Rahman F, Walters AH, Matheny RG, et al. Allergic response to medical products in patients with Alpha-gal syndrome. J Thorac Cardiovasc Surg. 2022;164(6):e411\u201324. https:\/\/doi.org\/10.1016\/j.jtcvs.2021.03.100.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"4270_CR17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1055\/s-0029-1185395","volume":"57","author":"A Mangold","year":"2009","unstructured":"Mangold A, Szerafin T, Hoetzenecker K, Hacker S, Lichtenauer M, Niederpold T, et al. Alpha-Gal specific IgG immune response after implantation of bioprostheses. Thorac Cardiovasc Surg. 2009;57(4):191\u20135. https:\/\/doi.org\/10.1055\/s-0029-1185395.","journal-title":"Thorac Cardiovasc Surg"},{"key":"4270_CR18","doi-asserted-by":"publisher","unstructured":"Pibarot P, Dumesnil JG. Prosthetic heart valves: selection of the optimal prosthesis and long-term management. Circulation https:\/\/doi.org\/10.5152\/AnatolJCardiol.2021.37670. PMID: 34369886; PMCID: PMC8357435.","DOI":"10.5152\/AnatolJCardiol.2021.37670"},{"issue":"2","key":"4270_CR19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/HCO.0000000000000711","volume":"35","author":"A Koziarz","year":"2020","unstructured":"Koziarz A, Makhdoum A, Butany J, Ouzounian M, Chung J. Modes of bioprosthetic valve failure: a narrative review. Curr Opin Cardiol. 2020;35(2):123\u201332. https:\/\/doi.org\/10.1097\/HCO.0000000000000711.","journal-title":"Curr Opin Cardiol"},{"issue":"7","key":"4270_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering10070833","volume":"10","author":"K As\u00f3s","year":"2023","unstructured":"As\u00f3s K, Llatj\u00f3s R, Blasco-Lucas A, Kuguel SG, Sbraga F, Galli C, et al. Differential immune response to bioprosthetic heart valve tissues in the \u03b11,3-galactosyltransferase-knockout mouse model. Bioengineering (Basel). 2023;10(7):833. https:\/\/doi.org\/10.3390\/bioengineering10070833.","journal-title":"Bioengineering (Basel)"},{"key":"4270_CR21","unstructured":"Gopal S, Hauser JM, Mahboobi SK. Mechanical aortic valve replacement [Internet]. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025 Jan\u2013 [updated 2024; cited 2025 Jul 24]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK564339\/"},{"issue":"6","key":"4270_CR22","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.athoracsur.2025.03.037","volume":"119","author":"DC Miller","year":"2025","unstructured":"Miller DC. Expanding transcatheter aortic valve replacement use in younger patients and bicuspid valves: risks, evidence gaps, and regulatory action. Ann Thorac Surg. 2025;119(6):1166\u201374. https:\/\/doi.org\/10.1016\/j.athoracsur.2025.03.037.","journal-title":"Ann Thorac Surg"},{"issue":"19","key":"4270_CR23","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1056\/NEJMoa1613792","volume":"377","author":"AB Goldstone","year":"2017","unstructured":"Goldstone AB, Chiu P, Baiocchi M, Lingala B, Patrick WL, Fischbein MP, et al. Mechanical or biologic prostheses for aortic-valve and mitral-valve replacement. N Engl J Med. 2017;377(19):1847\u201357. https:\/\/doi.org\/10.1056\/NEJMoa1613792.","journal-title":"N Engl J Med"},{"issue":"19","key":"4270_CR24","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.018506","volume":"9","author":"AE Kostyunin","year":"2020","unstructured":"Kostyunin AE, Yuzhalin AE, Rezvova MA, Ovcharenko EA, Glushkova TV, Kutikhin AG. Degeneration of bioprosthetic heart valves: update 2020. J Am Heart Assoc. 2020;9(19):e018506. https:\/\/doi.org\/10.1161\/JAHA.120.018506.","journal-title":"J Am Heart Assoc"},{"issue":"19","key":"4270_CR25","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1056\/NEJMoa1613792","volume":"377","author":"AB Goldstone","year":"2017","unstructured":"Goldstone AB, Chiu P, Baiocchi M, Lingala B, Patrick WL, Fischbein MP, et al. Mechanical or biologic prostheses for aortic-valve and mitral-valve replacement. N Engl J Med. 2017;377(19):1847\u201357. https:\/\/doi.org\/10.1056\/NEJMoa1613792.","journal-title":"N Engl J Med"},{"issue":"5","key":"4270_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13736","volume":"52","author":"D Traxler","year":"2022","unstructured":"Traxler D, Krotka P, Laggner M, Mildner M, Graf A, Reichardt B, et al. Mechanical aortic valve prostheses offer a survival benefit in 50\u201365 year olds: AUTHEARTVISIT study. Eur J Clin Invest. 2022;52(5):e13736. https:\/\/doi.org\/10.1111\/eci.13736.","journal-title":"Eur J Clin Invest"},{"issue":"19","key":"4270_CR27","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.018506","volume":"9","author":"AE Kostyunin","year":"2020","unstructured":"Kostyunin AE, Yuzhalin AE, Rezvova MA, Ovcharenko EA, Glushkova TV, Kutikhin AG. Degeneration of bioprosthetic heart valves: update 2020. Journal of the American Heart Association. 2020;9(19):e018506. https:\/\/doi.org\/10.1161\/JAHA.120.018506.","journal-title":"Journal of the American Heart Association"},{"issue":"9","key":"4270_CR28","doi-asserted-by":"publisher","first-page":"e005648","DOI":"10.1161\/JAHA.117.005648","volume":"6","author":"S Lee","year":"2017","unstructured":"Lee S, Levy RJ, Christian AJ, Hazen SL, Frick NE, Lai EK, et al. Calcification and oxidative modifications are associated with progressive bioprosthetic heart valve dysfunction. J Am Heart Assoc. 2017;6(9):e005648. https:\/\/doi.org\/10.1161\/JAHA.117.005648.","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"4270_CR29","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1111\/jocs.16325","volume":"37","author":"AF Hassanabad","year":"2022","unstructured":"Hassanabad AF, Ahsan MR, Hibino M. Valve deterioration: a victim of construct over time? J Card Surg. 2022;37(5):1230\u20132. https:\/\/doi.org\/10.1111\/jocs.16325.","journal-title":"J Card Surg"},{"key":"4270_CR30","first-page":"54","volume":"14","author":"P D\u2019Arrigo","year":"2020","unstructured":"D\u2019Arrigo P, Capodanno D. Structural valve deterioration and bioprosthetic valve failure: definitions, mechanisms, and treatment options. Cardiac Interventions Today. 2020;14:54\u201361.","journal-title":"Cardiac Interventions Today"},{"key":"4270_CR31","first-page":"54","volume":"14","author":"P D\u2019Arrigo","year":"2020","unstructured":"D\u2019Arrigo P, Capodanno D. Structural valve deterioration and bioprosthetic valve failure: definitions, mechanisms, and treatment options. Cardiac Interventions Today. 2020;14:54\u201361.","journal-title":"Cardiac Interventions Today"},{"key":"4270_CR32","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.xjon.2024.02.023","volume":"19","author":"BJJ Velders","year":"2024","unstructured":"Velders BJJ, Vriesendorp MD, Asch FM, Reardon MJ, Dagenais F, Moront MG, Sabik JF III, Groenwold RHH, Klautz RJM. Current definitions of hemodynamic structural valve deterioration after bioprosthetic aortic valve replacement lack consistency. JTCVS Open. eCollection; 2024;19:68\u201390. PMID:39015469; PMCID:PMC11247222.","journal-title":"JTCVS Open"},{"issue":"5","key":"4270_CR33","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1086\/500135","volume":"42","author":"H Lepidi","year":"2006","unstructured":"Lepidi H, Casalta JP, Fournier PE, Habib G, Collart F, Raoult D. Quantitative histological examination of bioprosthetic heart valves. Clin Infect Dis. 2006;42(5):590\u20136. https:\/\/doi.org\/10.1086\/500135.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"4270_CR34","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.jacbts.2023.01.003","volume":"8","author":"T Sakaue","year":"2023","unstructured":"Sakaue T, Koyama T, Nakamura Y, Okamoto K, Kawashima T, Umeno T, et al. Accumulation of circulating proteins and macrophages in the valve interstitium: novel mechanism of bioprosthetic valve deterioration. J Am Coll Cardiol Basic Trans Sci. 2023;8(7):862\u201380. https:\/\/doi.org\/10.1016\/j.jacbts.2023.01.003.","journal-title":"J Am Coll Cardiol Basic Trans Sci"},{"issue":"5","key":"4270_CR35","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2905181","volume":"29","author":"F Naso","year":"2024","unstructured":"Naso F, Gandaglia A, Sturaro G, Galli C, Melder RJ. The \u03b1-Gal KO mouse animal model is a reliable and predictive tool for the immune\u2011mediated calcification assessment of heart valve bioprostheses. Front Biosci (Landmark Ed). 2024;29(5):181. https:\/\/doi.org\/10.31083\/j.fbl2905181.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"5","key":"4270_CR36","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.hlc.2019.09.013","volume":"29","author":"A Ochi","year":"2020","unstructured":"Ochi A, Cheng K, Zhao B, Hardikar AA, Negishi K. Patient risk factors for bioprosthetic aortic valve degeneration: a systematic review and meta-analysis. Heart Lung Circ. 2020;29(5):668\u201378. https:\/\/doi.org\/10.1016\/j.hlc.2019.09.013.","journal-title":"Heart Lung Circ"},{"issue":"20","key":"4270_CR37","doi-asserted-by":"publisher","first-page":"9483","DOI":"10.1111\/jcmm.16937","volume":"25","author":"I Manduteanu","year":"2021","unstructured":"Manduteanu I, Simionescu D, Simionescu A, Simionescu M. Aortic valve disease in diabetes: molecular mechanisms and novel therapies. J Cell Mol Med. 2021;25(20):9483\u201395. https:\/\/doi.org\/10.1111\/jcmm.16937.","journal-title":"J Cell Mol Med"},{"issue":"2","key":"4270_CR38","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezac506","volume":"63","author":"YJ Jung","year":"2023","unstructured":"Jung YJ, Choi JW, Kang Y, Kim JS, Sohn SH, Hwang HY, et al. Long-term results of a stented bioprosthetic valve in the aortic position: structural valve deterioration and valve haemodynamic deterioration of bovine pericardial and porcine valves. Eur J Cardiothorac Surg. 2023;63(2):ezac506. https:\/\/doi.org\/10.1093\/ejcts\/ezac506.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"1","key":"4270_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0191171","volume":"13","author":"A Schaefer","year":"2018","unstructured":"Schaefer A, Dickow J, Schoen G, Westhofen S, Kloss L, Al-Saydali T, et al. Stentless vs stented bioprosthesis for aortic valve replacement: a case matched comparison of long-term follow-up and subgroup analysis of patients with native valve endocarditis. PLoS One. 2018;13(1):e0191171. https:\/\/doi.org\/10.1371\/journal.pone.0191171.","journal-title":"PLoS One"},{"issue":"3","key":"4270_CR40","doi-asserted-by":"publisher","first-page":"211","DOI":"10.21037\/acs-2023-aae-0166","volume":"13","author":"RT Hahn","year":"2024","unstructured":"Hahn RT, Pibarot P. Prosthesis-patient mismatch in transcatheter and surgical aortic valve replacement. Ann Cardiothorac Surg. 2024;13(3):211\u201323. https:\/\/doi.org\/10.21037\/acs-2023-aae-0166 . Epub 2024 Apr 28. PMID: 38841078; PMCID: PMC11148757.","journal-title":"Ann Cardiothorac Surg"},{"issue":"5","key":"4270_CR41","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.hlc.2019.09.013","volume":"29","author":"A Ochi","year":"2020","unstructured":"Ochi A, Cheng K, Zhao B, Hardikar AA, Negishi K. Patient risk factors for bioprosthetic aortic valve degeneration: a systematic review and meta-analysis. Heart Lung Circ. 2020;29(5):668\u201378. https:\/\/doi.org\/10.1016\/j.hlc.2019.09.013.","journal-title":"Heart Lung Circ"},{"issue":"1","key":"4270_CR42","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcr\/ytaf013","volume":"9","author":"M Sahebjam","year":"2025","unstructured":"Sahebjam M, Karimi Y, Fallah F. Complicated infective endocarditis of the bioprosthetic mitral valve following the transcatheter mitral valve-in-valve procedure: a case report and literature review. Eur Heart J Case Rep. 2025;9(1):ytaf013. https:\/\/doi.org\/10.1093\/ehjcr\/ytaf013.","journal-title":"Eur Heart J Case Rep"},{"key":"4270_CR43","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.yjmcc.2019.03.013","volume":"130","author":"G Manno","year":"2019","unstructured":"Manno G, Bentivegna R, Morreale P, Nobile D, Santangelo A, Novo S, et al. Chronic inflammation: a key role in degeneration of bicuspid aortic valve. J Mol Cell Cardiol. 2019;130:59\u201364. https:\/\/doi.org\/10.1016\/j.yjmcc.2019.03.013.","journal-title":"J Mol Cell Cardiol"},{"issue":"7","key":"4270_CR44","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1111\/jocs.12764","volume":"31","author":"RB Hawkins","year":"2016","unstructured":"Hawkins RB, Frischtak HL, Kron IL, Ghanta RK. Premature bioprosthetic aortic valve degeneration associated with allergy to galactose-alpha-1,3-galactose. J Card Surg. 2016;31(7):446\u20138. https:\/\/doi.org\/10.1111\/jocs.12764.","journal-title":"J Card Surg"},{"issue":"2","key":"4270_CR45","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41591-022-01682-w","volume":"28","author":"T Senage","year":"2022","unstructured":"Senage T, Paul A, Le Tourneau T, Fellah-Hebia I, Vadori M, Bashir S, et al. The role of antibody responses against glycans in bioprosthetic heart valve calcification and deterioration. Nat Med. 2022;28(2):283\u201394. https:\/\/doi.org\/10.1038\/s41591-022-01682-w.","journal-title":"Nat Med"},{"key":"4270_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s13019-024-02763-2","author":"K Taira","year":"2024","unstructured":"Taira K, Kanade R, Yammine M, Tannous H, Kumar S. Alpha-gal syndrome, a relative not absolute contraindication to the use of bovine pericardium to close an intracardiac septal defect: a case report. J Cardiothorac Surg. 2024;19(1):Article 63. https:\/\/doi.org\/10.1186\/s13019-024-02763-2."},{"issue":"4","key":"4270_CR47","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.athoracsur.2024.06.033","volume":"118","author":"S Chen","year":"2024","unstructured":"Chen S, Zeigler S. Safe implantation of a bovine bioprosthetic aortic valve in a patient with galactose-\u03b1-1,3-galactose allergy. Ann Thorac Surg. 2024;118(4):950\u20132. https:\/\/doi.org\/10.1016\/j.athoracsur.2024.06.033.","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"4270_CR48","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.atssr.2024.07.012","volume":"3","author":"B Aykut","year":"2024","unstructured":"Aykut B, Lim HK, Ngeve SM, Hoover A, Medina CK, Scherba J, et al. Perioperative outcomes after bioprosthetic valve replacement in patients sensitized to alpha-Gal. Ann Thorac Surg Short Rep. 2024;3(1):264\u20138. PMID: 40098868; PMCID: PMC11910761.","journal-title":"Ann Thorac Surg Short Rep"},{"issue":"32","key":"4270_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccas.2025.105478","volume":"30","author":"N Sami","year":"2025","unstructured":"Sami N, et al. Alpha-gal syndrome and aortic valve replacement. JACC Case Rep. 2025;30(32):105478. https:\/\/doi.org\/10.1016\/j.jaccas.2025.105478.","journal-title":"JACC Case Rep"},{"issue":"7","key":"4270_CR50","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1111\/jocs.12764","volume":"31","author":"RB Hawkins","year":"2016","unstructured":"Hawkins RB, Frischtak HL, Kron IL, Ghanta RK. Premature bioprosthetic aortic valve degeneration associated with allergy to galactose-alpha-1,3-galactose. J Card Surg. 2016;31(7):446\u20138. https:\/\/doi.org\/10.1111\/jocs.12764.","journal-title":"J Card Surg"},{"issue":"4","key":"4270_CR51","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.athoracsur.2024.06.033","volume":"118","author":"S Chen","year":"2024","unstructured":"Chen S, Zeigler S. Safe implantation of a bovine bioprosthetic aortic valve in a patient with galactose-\u03b1-1,3-galactose allergy. Ann Thorac Surg. 2024;118(4):950\u20132. https:\/\/doi.org\/10.1016\/j.athoracsur.2024.06.033.","journal-title":"Ann Thorac Surg"},{"issue":"32","key":"4270_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccas.2025.105478","volume":"30","author":"N Sami","year":"2025","unstructured":"Sami N, et al. Alpha-gal syndrome and aortic valve replacement. JACC Case Rep. 2025;30(32):105478. https:\/\/doi.org\/10.1016\/j.jaccas.2025.105478.","journal-title":"JACC Case Rep"},{"issue":"2","key":"4270_CR54","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41591-022-01682-w","volume":"28","author":"T Senage","year":"2022","unstructured":"Senage T, Paul A, Le Tourneau T, Fellah-Hebia I, Vadori M, Bashir S, et al. The role of antibody responses against glycans in bioprosthetic heart valve calcification and deterioration. Nat Med. 2022;28(2):283\u201394. https:\/\/doi.org\/10.1038\/s41591-022-01682-w.","journal-title":"Nat Med"},{"key":"4270_CR55","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2147\/ITT.S276872","volume":"11","author":"JD Macdougall","year":"2022","unstructured":"Macdougall JD, Thomas KO, Iweala OI. The meat of the matter: understanding and managing alpha-gal syndrome. Immunotargets Ther. 2022;11:37\u201354. https:\/\/doi.org\/10.2147\/ITT.S276872.","journal-title":"Immunotargets Ther"},{"issue":"4","key":"4270_CR56","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.athoracsur.2024.06.033","volume":"118","author":"S Chen","year":"2024","unstructured":"Chen S, Zeigler S. Safe implantation of a bovine bioprosthetic aortic valve in a patient with galactose-\u03b1-1,3-galactose allergy. Ann Thorac Surg. 2024;118(4):950\u20132. https:\/\/doi.org\/10.1016\/j.athoracsur.2024.06.033.","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"4270_CR57","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41591-022-01682-w","volume":"28","author":"T Senage","year":"2022","unstructured":"Senage T, Paul A, Le Tourneau T, Fellah-Hebia I, Vadori M, Bashir S, et al. The role of antibody responses against glycans in bioprosthetic heart valve calcification and deterioration. Nat Med. 2022;28(2):283\u201394. https:\/\/doi.org\/10.1038\/s41591-022-01682-w.","journal-title":"Nat Med"},{"issue":"9","key":"4270_CR58","doi-asserted-by":"publisher","first-page":"R389","DOI":"10.1016\/j.cub.2013.02.043","volume":"23","author":"MC Berin","year":"2013","unstructured":"Berin MC, Sampson HA. Mucosal immunology of food allergy. Curr Biol. 2013;23(9):R389\u2013400. https:\/\/doi.org\/10.1016\/j.cub.2013.02.043 . PMID: 23660362; PMCID: PMC3667506.","journal-title":"Curr Biol"},{"key":"4270_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2025.03.004","author":"LD Erickson","year":"2025","unstructured":"Erickson LD, Wilson JM, Cramton K, Rival CM. Pre-clinical strategies and emerging technologies driving advances in the alpha-gal syndrome. Allergol Int. 2025. https:\/\/doi.org\/10.1016\/j.alit.2025.03.004.","journal-title":"Allergol Int"},{"key":"4270_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.reval.2022.03.016","author":"B Zamorano","year":"2022","unstructured":"Zamorano B, Mailhol C, Atik H, Sakr Y, Trouche-Estival B, Apoil PA, et al. Sensitization and allergy to Alpha-galactose: mechanisms and clinical presentation. Rev Fr Allergol. 2022. https:\/\/doi.org\/10.1016\/j.reval.2022.03.016.","journal-title":"Rev Fr Allergol"},{"issue":"7","key":"4270_CR61","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1111\/jocs.12764","volume":"31","author":"RB Hawkins","year":"2016","unstructured":"Hawkins RB, Frischtak HL, Kron IL, Ghanta RK. Premature bioprosthetic aortic valve degeneration associated with allergy to galactose-alpha-1,3-galactose. J Card Surg. 2016;31(7):446\u20138. https:\/\/doi.org\/10.1111\/jocs.12764.","journal-title":"J Card Surg"},{"issue":"30","key":"4270_CR62","doi-asserted-by":"publisher","first-page":"815","DOI":"10.15585\/mmwr.mm7230a2","volume":"72","author":"JM Thompson","year":"2023","unstructured":"Thompson JM, Carpenter A, Kersh GJ, Wachs T, Commins SP, Salzer JS, for the CDC AGS Surveillance Working Group. Geospatial distribution of suspected alpha-gal syndrome cases \u2014 United States, January 2017\u2013December 2022. MMWR Morb Mortal Wkly Rep. 2023;72(30):815\u201320.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"4270_CR63","doi-asserted-by":"publisher","first-page":"830899","DOI":"10.3389\/fbioe.2022.830899","volume":"10","author":"F Naso","year":"2022","unstructured":"Naso F, Gandaglia A. Can heart valve decellularization be standardized? A review of the parameters used for the quality control of decellularization processes. Front Bioeng Biotechnol. 2022;10:830899. https:\/\/doi.org\/10.3389\/fbioe.2022.830899 . PMID: 35252139; PMCID: PMC8891751.","journal-title":"Front Bioeng Biotechnol"},{"key":"4270_CR64","doi-asserted-by":"publisher","DOI":"10.1111\/xen.12288","author":"U B\u00f6er","year":"2017","unstructured":"B\u00f6er U, Buettner FFR, Schridde A, Klingenberg M, Sarikouch S, Haverich A, et al. Antibody formation towards porcine tissue in patients implanted with crosslinked heart valves is directed to antigenic tissue proteins and \u03b1Gal epitopes and is reduced in healthy vegetarian subjects. Xenotransplantation. 2017. https:\/\/doi.org\/10.1111\/xen.12288.","journal-title":"Xenotransplantation"},{"issue":"13","key":"4270_CR65","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1097\/01.MIB.0000435437.76741.cb","volume":"19","author":"P Safaie","year":"2013","unstructured":"Safaie P, Ham M, Kuang P, Mehta AS, Wang M, Cheifetz AS, Robson S, Lau D, Block TM, Moss AC. Lectin-reactive anti-\u03b1-gal in patients with Crohn\u2019s disease: correlation with clinical phenotypes. Inflamm Bowel Dis. 2013;19(13):2796\u2013800. PMID: 24185312; PMCID: PMC4112456.","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"4270_CR66","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/xen.12044","volume":"20","author":"F Naso","year":"2013","unstructured":"Naso F, Gandaglia A, Bottio T, Tarzia V, Nottle MB, d\u2019Apice AJ, et al. First quantification of alpha-Gal epitope in current glutaraldehyde-fixed heart valve bioprostheses. Xenotransplantation. 2013;20(4):252\u201361. https:\/\/doi.org\/10.1111\/xen.12044.","journal-title":"Xenotransplantation"},{"issue":"2","key":"4270_CR67","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1161\/01.cir.95.2.479","volume":"95","author":"N Vyavahare","year":"1997","unstructured":"Vyavahare N, Hirsch D, Lerner E, Baskin JZ, Schoen FJ, Bianco R, et al. Prevention of bioprosthetic heart valve calcification by ethanol preincubation: efficacy and mechanisms. Circulation. 1997;95(2):479\u201388. https:\/\/doi.org\/10.1161\/01.cir.95.2.479.","journal-title":"Circulation"},{"issue":"9\u201310","key":"4270_CR68","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s12033-017-0024-9","volume":"59","author":"M Hryhorowicz","year":"2017","unstructured":"Hryhorowicz M, Zeyland J, S\u0142omski R, Lipi\u0144ski D. Genetically modified pigs as organ donors for xenotransplantation. Mol Biotechnol. 2017;59(9\u201310):435\u201344. https:\/\/doi.org\/10.1007\/s12033-017-0024-9 . PMID: 28698981; PMCID: PMC5617878.","journal-title":"Mol Biotechnol"},{"issue":"4","key":"4270_CR69","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezac583","volume":"63","author":"RJ Melder","year":"2023","unstructured":"Melder RJ, Naso F, Nicotra F, Russo L, Vesely I, Tuladhar SR, et al. Preventing extrinsic mechanisms of bioprosthetic degeneration using polyphenols. Eur J Cardiothorac Surg. 2023;63(4):ezac583. https:\/\/doi.org\/10.1093\/ejcts\/ezac583.","journal-title":"Eur J Cardiothorac Surg"},{"key":"4270_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1210098","volume":"14","author":"F Naso","year":"2023","unstructured":"Naso F, Colli A, Zilla P, Calafiore AM, Lotan C, Padalino MA, et al. Correlations between the alpha-Gal antigen, antibody response and calcification of cardiac valve bioprostheses: experimental evidence obtained using an alpha-Gal knockout mouse animal model. Front Immunol. 2023;14:1210098. https:\/\/doi.org\/10.3389\/fimmu.2023.1210098.","journal-title":"Front Immunol"},{"key":"4270_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1137827","volume":"10","author":"SK Singh","year":"2023","unstructured":"Singh SK, Kachel M, Castillero E, Xue Y, Kalfa D, Ferrari G, et al. Polymeric prosthetic heart valves: a review of current technologies and future directions. Front Cardiovasc Med. 2023;10:1137827. https:\/\/doi.org\/10.3389\/fcvm.2023.1137827.","journal-title":"Front Cardiovasc Med"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-026-04270-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-026-04270-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-026-04270-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:22:21Z","timestamp":1790248941000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13019-026-04270-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4270"],"URL":"https:\/\/doi.org\/10.1186\/s13019-026-04270-y","relation":{"references":[{"id-type":"doi","id":"10.1186\/s13019-024-02763-2","asserted-by":"subject"}]},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"assertion":[{"value":"22 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Jack Gosden reports no disclosures. Guido Ascione reports no disclosures. Seth Wolf reports no disclosures. Joseph W. Turek reports no disclosures. Isaac George reports the following disclosures: Grant Support: Medtronic, Boston Scientific, Edwards Lifesciences Consultant (honoraria) \u2013 Zimmer Biomet, Atricure, Neosurgery, Neptune Medical, Abbvie, Johnson & Johnson, Durvena, Boston Scientific, Edwards Lifesciences, Medtronic, Encompass Medical, Summus Medical, Abbott SJM, BCI, Xeltis, Innocardiac, KIS Medical Advisory Boards: Edwards Surgical, Medtronic Surgical, Medtronic Structural Mitral & Tricuspid, Trisol Medical, Valcare Medical, Durvena, Abbvie, Johnson & Johnson, Foldax Medical, Zimmer Biomet, Neosurgery, Abbvie, Boston Scientific, Summus Medical, BCI, Encompass Medical, HVT Medical, Innocardiac, KIS Medical, Retex Medical, Abbott Global TAVI Equity: Valcare Medical, Durvena, CardioMech, Vdyne, MitreMedical, BCI, Trisol Medical, HVT Medical, Foldax, KIS Medical Institutional funding to Columbia University: Edwards Lifesciences, Medtronic, Abbott Vascular, Boston Scientific, JenaValve.Jack Gosden reports no disclosures.","order":1,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Isaac George reports a relationship with Medtronic that includes: consulting or advisory and funding grants. Isaac George reports a relationship with Boston Scientific Corporation that includes: consulting or advisory and funding grants. Isaac George reports a relationship with Edwards Lifesciences Corporation that includes: consulting or advisory and funding grants. Isaac George reports a relationship with Zimmer Biomet that includes: consulting or advisory. Isaac George reports a relationship with AtriCure Inc that includes: consulting or advisory. Isaac George reports a relationship with Neosurgery that includes: consulting or advisory. Isaac George reports a relationship with Neptune Medical that includes: consulting or advisory. Isaac George reports a relationship with AbbVie Inc that includes: consulting or advisory. Isaac George reports a relationship with Johnson & Johnson that includes: consulting or advisory. Isaac George reports a relationship with Durvena that includes: consulting or advisory and equity or stocks. Isaac George reports a relationship with Encompass medical that includes: consulting or advisory. Isaac George reports a relationship with Foldax medical that includes: consulting or advisory and equity or stocks. Isaac George reports a relationship with Summus Medical that includes: consulting or advisory. Isaac George reports a relationship with Xeltis that includes: consulting or advisory. Isaac George reports a relationship with Innocardiac that includes: consulting or advisory. Isaac George reports a relationship with KIS medical that includes: consulting or advisory and equity or stocks. Isaac George reports a relationship with Trisol Medical that includes: consulting or advisory and equity or stocks. Isaac George reports a relationship with Valcare medical that includes: consulting or advisory and equity or stocks. Isaac George reports a relationship with HVT medical that includes: consulting or advisory. Isaac George reports a relationship with Retex medical that includes: consulting or advisory. Isaac George reports a relationship with Abbott that includes: consulting or advisory and funding grants. Isaac George reports a relationship with CardioMech that includes: equity or stocks. Isaac George reports a relationship with Vdyne that includes: equity or stocks. Isaac George reports a relationship with MitreMedical that includes: equity or stocks. Isaac George reports a relationship with BCI that includes: equity or stocks. Isaac George reports a relationship with HVT medical that includes: equity or stocks. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"719"}}